10 research outputs found
Associations of Lp-PLA<sub>2</sub> mass with intracranial and extracranial arterial stenosis.
<p>OR, odds ratio. Model I adjusted for age and sex. Model II adjusted for age, sex, BMI, hypertension duration, current smoking and drinking status, diabetes, LDL, HDL, plasma glucose, mean arterial pressure, heart rate, neutrophil account, urine albumin creatinine ratio, serum creatinine, anti-hypertensive treatment, and statin use. The odds ratio expressed the risk in the ICAS and ECAS group compared with the non-stenosis group. Isolated ECAS, extracranial arterial stenosis only; Isolated ICAS, intracranial arterial stenosis only; COMB, combined extra- and intracranial arterial stenosis. Complex ICAS, intracranial arterial stenosis no matter how was the extracranial arteries; Hypertension duration, neutrophil account, serum creatinine, urine albumin creatinine ratio and Lp-PLA<sub>2</sub> are log-transformed.</p><p>Associations of Lp-PLA<sub>2</sub> mass with intracranial and extracranial arterial stenosis.</p
Prevalence of moderate to severe ECAS and ICAS (%) (A) and distribution of ICAS vessels (B) according to tertiles of Lp-PLA<sub>2</sub>.
<p>ECAS, extracranial arterial stenosis; ICAS, intracranial arterial stenosis; Lp-PLA2, Lipoprotein-associated phospholipase A<sub><b>2</b></sub>.</p
Crude and adjusted syphilis prevalence and risk behavior indicators among female sex workers, Jinan, China from 2008 to 2009.
<p>Crude and adjusted syphilis prevalence and risk behavior indicators among female sex workers, Jinan, China from 2008 to 2009.</p
The protocols of the related drugs to a total of 453 eligible patients in the study.
<p>N = number; W = week; ETW = every two weeks; EQW = every four weeks.</p
The hypotensive effects of α,β-ADR blockers between KCNH2(C1966T) genotypes(CC v.s CT+TT) and age(≤55 y v.s 55 y), gender(Men v.s Women)interactions in EH patients.
*<p>P-values were with bonferroni adjust and BMI, gender ,age adjust were appropriately use in the model,ΔHR4 = heart rate change at the end of 4 weeks, ΔDBP4 = diastolic pressure change at the at the end of 4 weeks,ΔMAP4 = mean arterial pressure change at the at the end of 4 weeks,ΔDBP6 = diastolic pressure change at the end of 6weeks, ΔMAP6 = mean arterial pressure change at the end of 6 weeks.</p
Stratified analyses of the difference hypotensive effects of α,β-ADR blockers between KCNH2 (1956,C>T) genotypes(CC v.s CT+TT) and age(≤55 y v.s 55 y), gender(Men v.s Women)interactions in EH patients.
*<p>P-values were with bonferroni adjust and BMI, gender ,age adjust were appropriately use in the model,ΔHR4 = heart rate change at the end of 4 weeks, ΔDBP4 = diastolic pressure change at the at the end of 4 weeks,ΔMAP4 = mean arterial pressure change at the at the end of 4 weeks, ΔPP4 = pulse pressure change at the end of 4 weeks, ΔDBP6 = diastolic pressure change at the end of 6weeks, ΔMAP6 = mean arterial pressure change at the end of 6 weeks.</p
The relationship between <i>KCNH2</i> (C1956T) genetic polymorphism and the hypotensive effects of CCBs (azelnidipine & nitrendipine).
<p>Absolute changes in SBP (A), DBP (B), and MAP (C) in EH patients carrying the KCNH2 (1956,C>T) CC and CT+TT genotypes after treatment with azelnidipine or nitrendipine for 2, 4, and 6 weeks.*<i>P</i><0.05(without age, BMI, and gender adjustment), error bar indicated 95% confidence interval.</p
The relationship between the <i>RGS2</i> (-391, C>G) genetic polymorphism and the hypotensive effects of candesartan, irbesartan or imidapril monotherapy in EH patients.
<p>*<i>P-</i>values are shown with age, BMI, and gender adjustments. The error bar indicates 95% CI.</p
Comparison of the baseline characteristics of the eligible patients in the <i>RGS2</i> (-391, C>G) genotype groups.
<p>Data are expressed as means ± SD. BMI indicates body mass index; HR, heart rate; SBP, systolic blood pressure; DBP, diastolic blood pressure; PP, pulse pressure; MAP, mean arterial pressure; ALT, alanine aminotransferase; BUN, blood urea nitrogen, UCr, urine creatinine; UA, uric acid; FBG, fasting blood glucose; TG, triglyceride; CHO, cholesterol; HDL, high-density lipoprotein; and LDL, low-density lipoprotein.</p><p>Comparison of the baseline characteristics of the eligible patients in the <i>RGS2</i> (-391, C>G) genotype groups.</p
Factors Associated with Willingness to Accept Oral Fluid HIV Rapid Testing among Most-at-Risk Populations in China
<div><p>Background</p><p>The availability of oral fluid HIV rapid testing provides an approach that may have the potential to expand HIV testing in China, especially among most-a-risk populations. There are few investigations about the acceptability of oral fluid HIV testing among most-at-risk populations in China.</p> <p>Method</p><p>A cross-sectional study with men who have sex with men (MSM), female sex workers (FSW) and voluntary counseling and testing (VCT) clients was conducted in three cities of Shandong province, China from 2011 to 2012. Data were collected by face-to-face questionnaire.</p> <p>Results</p><p>About 71% of participants were willing to accept the oral fluid HIV rapid testing, and home HIV testing was independently associated with acceptability of the new testing method among MSM, FSW and VCT clients (AOR of 4.46, 3.19 and 5.74, respectively). Independent predictors of oral fluid HIV rapid testing acceptability among MSM were having ever taken an oral fluid HIV rapid test (AOR= 15.25), having ever taken an HIV test (AOR= 2.07), and education level (AOR= 1.74). Engagement in HIV-related risk behaviors (AOR= 1.68) was an independent predictor of acceptability for FSW. Having taken an HIV test (AOR= 2.85) was an independent predictor of acceptability for VCT clients. The primary concern about the oral fluid HIV testing was accuracy. The median price they would pay for the testing ranged from 4.8 to 8.1 U.S. dollars.</p> <p>Conclusion</p><p>High acceptability of oral fluid HIV rapid testing was shown among most-at-risk populations. Findings provide support for oral rapid HIV testing as another HIV prevention tool, and provide a backdrop for the implementation of HIV home testing in the near future. Appropriate pricing and increased public education through awareness campaigns that address concerns about the accuracy and safety of the oral fluid HIV rapid testing may help increase acceptability and use among most-at-risk populations in China.</p> </div